Gastroretentive Drug Delivery Systems Outsourcing Market Forecast: Breaking Down The Numbers Behind Future Expansion

Gastroretentive Drug Delivery Systems Outsourcing Market Report

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Gastroretentive Drug Delivery Systems Outsourcing Market Forecast: Value Set To Climb From $1.61 Billion To $2.1 Billion

The gastroretentive drug delivery systems outsourcing market size has demonstrated robust growth over recent years. This market is anticipated to expand from $1.49 billion in 2025 to $1.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.8%. The historical development of this market can be ascribed to several factors including the constraints of traditional oral drug delivery, an increase in CRO services, the necessity for better drug absorption, the broadening of the pharmaceutical pipeline, and innovations in formulation technology.

The gastroretentive drug delivery systems outsourcing market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $2.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth during the forecast timeframe include the rising complexity of drug molecules, a growing need for patient-focused delivery systems, broadened outsourcing approaches, advancements in gastroretentive technologies, and pharmaceutical companies’ drive for cost efficiency. Key trends identified for this period encompass the increasing trend of outsourcing advanced drug delivery development, higher demand for formulations with extended gastrointestinal retention, the increasing implementation of floating drug delivery systems, a widening of CRO collaborations in formulation development, and a strong emphasis on improving drug bioavailability.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=94744993&type=smp&name=Gastroretentive%20Drug%20Delivery%20Systems%20Outsourcing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Gastroretentive Drug Delivery Systems Outsourcing Market Development Factors: What’s Supporting Demand?

The increasing occurrence of gastrointestinal ailments is anticipated to fuel the expansion of the gastroretentive drug delivery systems outsourcing market. These disorders encompass various conditions impacting the digestive tract, such as the stomach, liver, gallbladder, intestines, and pancreas. Factors contributing to the rise in gastrointestinal disorders include an aging population, antibiotic consumption, infectious agents, shifts in diet, stress, lifestyle choices, and obesity. By outsourcing gastroretentive drug delivery systems, pharmaceutical firms gain the necessary resources and specialized knowledge to manage the increasing impact of gastrointestinal conditions, which in turn enhances patient health and overall well-being. For example, in August 2023, the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based government-funded research institute and public health agency, indicated that 60 to 70 million people were affected by all digestive diseases. Consequently, the growing incidence of gastrointestinal disorders is propelling the gastroretentive drug delivery systems outsourcing market. The rising occurrence of age-related conditions is projected to stimulate the expansion of gastroretentive drug delivery systems in the future. These disorders encompass a wide array of medical issues and functional decline primarily affecting seniors, such as cardiovascular ailments, neurodegenerative conditions, musculoskeletal problems, and sensory deficits. The incidence of these conditions is increasing due to an aging global population, extended lifespans, lifestyle elements, and the aggregation of chronic diseases. For example, in April 2025, the Centers for Disease Control and Prevention, a US-based government public health agency, reported that in 2023, around 194 million American adults, including 6 in 10 young adults, 8 in 10 midlife adults, and 9 in 10 older adults, had one or more conditions. The prevalence of chronic conditions saw an increase of 7.0 percentage points among young adults. Thus, the growing prevalence of age-related disorders is fueling the gastroretentive drug delivery systems outsourcing market.

Gastroretentive Drug Delivery Systems Outsourcing Market Segment Outlook: Which Categories Are Growing Fastest?

The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –

1) By Type: Floating Systems, Bioadhesive Systems, Other Types

2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms

3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications

4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:

1) By Floating Systems: Single Unit Systems, Multiple Unit Systems

2) By Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers

3) By Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems

Gastroretentive Drug Delivery Systems Outsourcing Market Trends Powering Strategic Industry Growth

Companies operating within the gastroretentive drug delivery systems outsourcing market are concentrating on developing innovative products, such as ready-to-fill (RTF) colon functional capsules, to boost drug delivery efficiency and patient convenience. Ready-to-fill (RTF) colon functional capsules refer to pre-manufactured, empty capsules designed to be filled with specific formulations or active ingredients tailored for the colon. For instance, in September 2024, Evonik, a Germany-based advanced drug delivery provider, launched EUDRACAP colon functional capsules, engineered for the targeted delivery of oral drugs to the ileo-colonic region. These novel capsules are the first ready-to-fill option available in the market, intended for delivering sensitive active ingredients like live biotherapeutic products (LBPs). Currently provided in technical grade, a GMP-grade product is also being developed. EUDRACAP colon streamlines the oral drug development process by simplifying formulation and accelerating time to market, thereby representing a significant advancement in gastroretentive drug delivery systems.

Gastroretentive Drug Delivery Systems Outsourcing Market Leading Companies And Competitive Benchmarking

Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, Evonik Industries AG, SGS SA, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc, Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

View The Full Gastroretentive Drug Delivery Systems Outsourcing Market Report:

https://thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Nov_PR

Gastroretentive Drug Delivery Systems Outsourcing Market Global Footprint: Which Region Leads The Market?

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model